15-51094649-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000327536.5(TNFAIP8L3):c.211G>A(p.Glu71Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000175 in 1,370,042 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000327536.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TNFAIP8L3 | NM_001311175.2 | c.-54G>A | 5_prime_UTR_variant | 1/2 | ENST00000637513.2 | ||
MIR4713HG | NR_146310.1 | n.194+56968C>T | intron_variant, non_coding_transcript_variant | ||||
TNFAIP8L3 | NM_207381.4 | c.211G>A | p.Glu71Lys | missense_variant | 2/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TNFAIP8L3 | ENST00000327536.5 | c.211G>A | p.Glu71Lys | missense_variant | 2/3 | 1 | |||
TNFAIP8L3 | ENST00000637513.2 | c.-54G>A | 5_prime_UTR_variant | 1/2 | 1 | NM_001311175.2 | P1 | ||
MIR4713HG | ENST00000559909.1 | n.194+56968C>T | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.00000665 AC: 1AN: 150420Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000316 AC: 1AN: 31668Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 18408
GnomAD4 exome AF: 0.0000189 AC: 23AN: 1219622Hom.: 0 Cov.: 30 AF XY: 0.0000167 AC XY: 10AN XY: 597182
GnomAD4 genome AF: 0.00000665 AC: 1AN: 150420Hom.: 0 Cov.: 33 AF XY: 0.0000136 AC XY: 1AN XY: 73426
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2023 | The c.211G>A (p.E71K) alteration is located in exon 2 (coding exon 2) of the TNFAIP8L3 gene. This alteration results from a G to A substitution at nucleotide position 211, causing the glutamic acid (E) at amino acid position 71 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at